Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers

Acta Biomaterialia

Volumn 6, Issue 6, 2010, Pages 1978-1991

  Wang, Feng ^a   Li, Zhenqing ^a   Khan, Mahmood ^b   Tamama, Kenichi ^b   Kuppusamy, Periannan ^b   Wagner, William R ^c   Sen, Chandan K ^b   Guan, Jianjun ^a  

^a Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Composite; Human mesenchymal stromal cell; Hydrogel; Insulin like growth factor; Release

Indexed keywords

ACRYLIC MONOMERS; AMIDES; BIOMECHANICS; CELL ENGINEERING; CELLS; COLLAGEN; FLOWCHARTING; GELATION; OXYGEN; PHYSIOLOGY; SULFUR COMPOUNDS; TISSUE; TISSUE CULTURE; TISSUE ENGINEERING;

CELL CARRIER; CHONDROITINSULFATE; GROWTH CELLS; GROWTH FACTOR CARRIERS; HUMAN MESENCHYMAL STROMAL CELL; HYDROGELS COMPOSITES; INJECTABLES; INSULIN-LIKE GROWTH FACTOR; MESENCHYMAL STROMAL CELLS; RELEASE;

HYDROGELS;

ACRYLIC ACID; CHONDROITIN SULFATE; COLLAGEN TYPE 1; COPOLYMER; METHACRYLIC ACID; N ACRYLOXYSUCCINIMIDE; POLY(N ISOPROPYLACRYLAMIDE); POLY(TRIMETHYLENE CARBONATE) HYDROXYETHYL METHACRYLATE; POLY(TRIMETHYLENE CARBONATE) HYDROXYETHYLMETHACRYLATE; SOMATOMEDIN C; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; SIGNAL PEPTIDE;

ARTICLE; BIODEGRADATION; BODY TEMPERATURE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GELATION; HEART MUSCLE; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYME CELL; NONHUMAN; OXYGEN TENSION; PERMEABILITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WATER CONTENT; ABSORPTION; CELL CULTURE; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; INJECTION; MATERIALS TESTING; MESENCHYMAL STEM CELL; METHODOLOGY; PARTICLE SIZE; PHYSIOLOGY; POROSITY; SURFACE PROPERTY; TISSUE ENGINEERING;

RATTUS;

ABSORPTION; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DRUG CARRIERS; HUMANS; HYDROGELS; INJECTIONS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATERIALS TESTING; MESENCHYMAL STEM CELLS; PARTICLE SIZE; POROSITY; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 77956621279     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.12.011     Document Type: Article

References (74)

1. Pedersen JA, Swartz MA. Mechanobiology in the third dimension. Ann Biomed Eng 2005;33(11):1469-90.
2. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126(4):677-89.
3. Baroli B. Hydrogels for tissue engineering and delivery of tissue-inducing substances. J Pharm Sci 2007;96(9):2197-223.
4. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng B Rev 2008;14(2):149-65.
5. Carbonetto ST, Gruver MM, Turner DC. Nerve fiber growth on defined hydrogel substrates. Science 1982;216(4548):897-9.
6. Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008;37(8):1473-81.
7. Van Tomme SR, Storm G, Hennink WE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm 2008;355(1-2): 1-18.
8. Aliyar HA, Hamilton PD, Ravi N. Refilling of ocular lens capsule with copolymeric hydrogel containing reversible disulfide. Biomacromolecules 2005;6(1):204-11.
9. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo (poly (ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005;101(1-3): 111-25.
10. Guo X, Park H, Liu G, Liu W, Cao Y, Tabata Y, et al. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 2009;30(14):2741-52.
11. Guan J, Hong Y, Ma Z, Wagner WR. Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability. Biomacromolecules 2008;9(4):1283-92.
12. Hennink WE, van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev 2002;54(1):13-36.
13. Nguyen KT, West JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002;23(22):4307-14.
14. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54(1):37-51.
15. Tate MC, Shear DA, Hoffman SW, Stein DG, LaPlaca MC. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 2001;22(10):1113-23.
16. Ruel-Gariepy E, Leroux JC. In situ-forming hydrogels - review of temperaturesensitive systems. Eur J Pharm Biopharm 2004;58(2):409-26.
17. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997;388(6645):860-2.
18. Raucher D, Massodi I, Bidwell GL. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide. Expert Opin Drug Deliv 2008;5(3):353-69.
19. Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002;54(5):613-30.
20. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002;90(3):e40-8.
21. Takeda N, Nakamura E, Yokoyama M, Okano T. Temperature-responsive polymeric carriers incorporating hydrophobic monomers for effective transfection in small doses. J Control Release 2004;95(2):343-55.
22. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68(1):34-45.
23. Li F, Carlsson D, Lohmann C, Suuronen E, Vascotto S, Kobuch K, et al. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA 2003;100(26):15346-51.
24. Guan J, Wagner WR, Fujimoto KL. Thermoresponsive, biodegradable, elastomeric material. US Patent No. 0096975A1; 2008.
25. Guan J, Hong Y, Ma Z, Wagner WR. Protein-reactive, injectable, thermosensitive and flexible hydrogels. 2008 World Congress of Biomaterials (#1776). Amsterdam; 2008.
26. Lee JE, Kim KE, Kwon IC, Ahn HJ, Lee SH, Cho HC, et al. Effects of the controlledreleased TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 2004;25(18):4163-73.
27. Pieper JS, van Wachem PB, van Luyn MJA, Brouwer LA, Hafmans T, Veerkamp JH, van Kuppevelt TH. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials 2000;21:1689-99.
28. Pandian RP, Parinandi NL, Ilangovan G, Zweier JL, Kuppusamy P. Novel particulate spin probe for targeted determination of oxygen in cells and tissues. Free Radic Biol Med 2003;35(9):1138-48.
29. Khan M, Kutala VK, Vikram DS, Wisel S, Chacko SM, Kuppusamy ML, et al. Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am J Physiol Heart Circ Physiol 2007;293(4):H2129-39.
30. Kutala VK, Parinandi NL, Pandian RP, Kuppusamy P. Simultaneous measurement of oxygenation in intracellular and extracellular compartments of lung microvascular endothelial cells. Antioxid Redox Signal 2004;6(3):597-603.
31. Elvira C, Mano JF, San Román J, Reis RL. Starch-based biodegradable hydrogels with potential biomedical applications as drug delivery systems. Biomaterials 2002;23(9):1955-66.
32. Reddy TT, Kano A, Maruyama A, Hadano M, Takahara A. Thermosensitive transparent semi-interpenetrating polymer networks for wound dressing and cell adhesion control. Biomacromolecules 2008;9(4):1313-21.
33. Guan J, Stankus JJ, Wagner WR. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release 2007;120(1-2): 70-8.
34. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 2001;56(2):216-21.
35. Du J, Cai SH, Suzuki H, Akhand AA, Ma XY, Takagi Y, et al. Involvement of MEKK1/ERK/P21 (Waf1/Cip1) signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal. J Cell Biochem 2003;88(6):1235-46.
36. Yow SZ, Quek CH, Yim KF, Lim CT, Leong KW. Collagen-based fibrous scaffold for spatial organization of encapsulated and seeded human mesenchymal stem cells. Biomaterials 2009;30:1133-42.
37. Song L, Webb NE, Song Y, Tuan RS. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 2006;24(7):1707-18.
38. Yu J, Gu Y, Du KT, Mihardja S, Sievers RE, Lee RJ. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 2009;30(5):751-6.
39. Cho MH, Kim KS, Ahn HH, Kim MS, Kim SH, Khang G, et al. Chitosan gel as an in situ-forming scaffold for rat bone marrow mesenchymal stem cells in vivo. Tissue Eng A 2008;14(6):1099-108.
40. Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005;100(3):217-23.
41. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73(6):1919-25.
42. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105(1):93-8.
43. Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008;456(7221):502-6.
44. Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, et al. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med 2008;36(12):2354-62.
45. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006;48(5):907-13.
46. Reffelmann T, Kloner RA. Cellular cardiomyoplasty - cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res 2003;58(2):358-68.
47. Radosevich JA, Haines GK, Elseth KM, Shambaugh 3rd GE, Maker VK. A new method for the detection of viable cells in tissue sections using 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT): an application in the assessment of tissue damage by surgical instruments. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;63(6):345-50.
48. Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng A 2008;14(6):1025-36.
49. Nuttelman CR, Tripodi MC, Anseth KS. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 2005;24(3):208-18.
50. Ryu JH, Kim IK, Cho SW. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005;26(3):319-26.
51. Thompson CA, Nasseri BA, Makower J. Percutaneous transvenous cellular ardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003;41(11):1964-71.
52. Kofidis T, de Bruin JL, Hoyt G. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004;128(4):571-8.
53. Davis ME, Motion JP, Narmoneva DA. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005;111(4):442-50.
54. Yeo Y, Geng WL, Ito T, et al. Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater 2007;81(2):312-22.
55. Tsur-Gang O, Ruvinov E, Landa N, Holbova R, Feinberg MS, Leor J, et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 2009;30(2):189-95.
56. Wang T, Wu DQ, Jiang XJ, Zhang XZ, Li XY, Zhang JF, et al. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodeling. Eur J Heart Fail 2009;11(1):14-9.
57. Lee BH, Vernon B. In situ-gelling, erodible N-isopropylacrylamide copolymers. Macromol Biosci 2005;5(7):629-35.
58. Kim S, Healy KE. Synthesis and characterization of injectable poly (N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003;4(5):1214-23.
59. Neradovic D, Soga O, Van Nostrum CF, Hennink WE. The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly (ethylene glycol) and poly (N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials 2004;25(12):2409-18.
60. Aoki M, Morishita R, Higaki J, Moriguchi A, Kida I, Hayashi S, et al. In vivo transfer efficiency of antisense oligonucleotides into the myocardium using HVJ-liposome method. Biochem Biophys Res Commun 1997;231(3):540-5.
61. Elbjeirami WM, Yonter EO, Starcher BC, West JL. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J Biomed Mater Res A 2003;66(3):513-21.
62. Wen Q, Basu A, Winer JP, Yodh AG, Janmey PA. Local, global deformations in a strain-stiffening fibrin gel. New J Phys 2007;9:428.
63. Janmey PA, Mccormick ME, Rammensee S, Leight JL, Georges PC, MacKintosh FC. Negative normal stress in semiflexible biopolymer gels. Nat Mater 2007;6(1):48-51.
64. Chen JP, Cheng TH. Preparation and evaluation of thermo-reversible copolymer hydrogels containing chitosan and hyaluronic acid as injectable cell carriers. Polymer 2009;50(1):107-16.
65. Vallée F, Müller C, Durand A, Schimchowitsch S, Dellacherie E, Kelche C, et al. Synthesis and rheological properties of hydrogels based on amphiphilic alginate-amide derivatives. Carbohydr Res 2009;344(2):223-8.
66. Schmedlen RH, Masters KS, West JL. Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. Biomaterials 2002;23(22):4325-32.
67. Chen QZ, Harding SE, Ali NN, Lyon AR, Boccaccini AR. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater Sci Eng R 2008;59(1):1-37.
68. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006;114(24):2627-35.
69. Pego AP, van Luyn MJA, Brouwer LA, van Wachem PB, Poot AA, Grijpma DW, et al. In vivo behavior of poly (1, 3-trimethylene carbonate) and copolymers of 1, 3-trimethylene carbonate with D, L-lactide or epsilon-caprolactone: degradation and tissue response. J Biomed Mater Res A 2003;67:1044-54.
70. Huang YC, Khait L, Birla RK. Modulating the functional performance of bioengineered heart muscle using growth factor stimulation. Ann Biomed Eng 2008;36:1372-82.
71. Laviola L, Natalicchio A, Giorgino F. The IGF-I signaling pathway. Curr Pharm Des 2007;13(7):663-9.
72. Opgaard OS, Wang PH. IGF-I is a matter of heart. Growth Horm IGF Res 2005;15(2):89-94.
73. Yow SZ, Quek CH, Yim EK, Lim CT, Leong KW. Collagen-based fibrous scaffold for spatial organization of encapsulated and seeded human mesenchymal stem cells. Biomaterials 2009;30(6):1133-42.
74. Chamberlain G, Fox J, Ashton B, Middleton J. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25(11):2739-49.